FinanceAquaculture biotech group Benchmark put up for saleThe board believes the company's current share price 'materially undervalues' the business.Almost half of Benchmark's shares are held by Norwegian investors. Gustav Witzoe's Kverva is one of the largest.Photo: Hedvig IdåsRachel Mutter
